777 related articles for article (PubMed ID: 33470550)
1. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
Zhou X; Smith QR; Liu X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
[TBL] [Abstract][Full Text] [Related]
2. Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors.
Jafari B; Pourseif MM; Barar J; Rafi MA; Omidi Y
Expert Opin Drug Deliv; 2019 Jun; 16(6):583-605. PubMed ID: 31107110
[TBL] [Abstract][Full Text] [Related]
3. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
Kristensen M; Brodin B
J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
[TBL] [Abstract][Full Text] [Related]
4. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
Tashima T
Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
[TBL] [Abstract][Full Text] [Related]
5. Penetrating the Blood-Brain Barrier with New Peptide-Porphyrin Conjugates Having anti-HIV Activity.
Mendonça DA; Bakker M; Cruz-Oliveira C; Neves V; Jiménez MA; Defaus S; Cavaco M; Veiga AS; Cadima-Couto I; Castanho MARB; Andreu D; Todorovski T
Bioconjug Chem; 2021 Jun; 32(6):1067-1077. PubMed ID: 34033716
[TBL] [Abstract][Full Text] [Related]
6. Harnessing the capacity of cell-penetrating peptides for drug delivery to the central nervous system.
Kang T; Gao X; Chen J
Curr Pharm Biotechnol; 2014; 15(3):220-30. PubMed ID: 24938893
[TBL] [Abstract][Full Text] [Related]
7. Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges.
Parrasia S; Szabò I; Zoratti M; Biasutto L
Mol Pharm; 2022 Nov; 19(11):3700-3729. PubMed ID: 36174227
[TBL] [Abstract][Full Text] [Related]
8. Transcellular brain drug delivery: A review on recent advancements.
Azarmi M; Maleki H; Nikkam N; Malekinejad H
Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
[TBL] [Abstract][Full Text] [Related]
9. Food-Derived Peptides: Beneficial CNS Effects and Cross-BBB Transmission Strategies.
Li Z; Dang Q; Wang P; Zhao F; Huang J; Wang C; Liu X; Min W
J Agric Food Chem; 2023 Dec; 71(51):20453-20478. PubMed ID: 38085598
[TBL] [Abstract][Full Text] [Related]
10. Application of the Phage Display Technology for the Development of Peptide- mediated Drug Delivery Systems through the Blood-Brain Barrier.
Suárez VM; Vispo NS; Ramos OS
Curr Pharm Biotechnol; 2021; 22(11):1394-1403. PubMed ID: 33397231
[TBL] [Abstract][Full Text] [Related]
11. Jumping Hurdles: Peptides Able To Overcome Biological Barriers.
Sánchez-Navarro M; Teixidó M; Giralt E
Acc Chem Res; 2017 Aug; 50(8):1847-1854. PubMed ID: 28715199
[TBL] [Abstract][Full Text] [Related]
12. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.
Xie J; Shen Z; Anraku Y; Kataoka K; Chen X
Biomaterials; 2019 Dec; 224():119491. PubMed ID: 31546096
[TBL] [Abstract][Full Text] [Related]
13. Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.
Zhang W
Handb Exp Pharmacol; 2024; 284():213-230. PubMed ID: 37528323
[TBL] [Abstract][Full Text] [Related]
14. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
15. A New Noncanonical Anionic Peptide That Translocates a Cellular Blood-Brain Barrier Model.
Neves-Coelho S; Eleutério RP; Enguita FJ; Neves V; Castanho MARB
Molecules; 2017 Oct; 22(10):. PubMed ID: 29057814
[TBL] [Abstract][Full Text] [Related]
16. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
Kanazawa T
Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
[TBL] [Abstract][Full Text] [Related]
17. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
Patel MM; Patel BM
CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766
[TBL] [Abstract][Full Text] [Related]
18. CNS drug delivery systems: novel approaches.
Pathan SA; Iqbal Z; Zaidi SM; Talegaonkar S; Vohra D; Jain GK; Azeem A; Jain N; Lalani JR; Khar RK; Ahmad FJ
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):71-89. PubMed ID: 19149731
[TBL] [Abstract][Full Text] [Related]
19. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
20. CNS delivery via adsorptive transcytosis.
Hervé F; Ghinea N; Scherrmann JM
AAPS J; 2008 Sep; 10(3):455-72. PubMed ID: 18726697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]